India’s Cipla Ltd. Gets Tentative U.S. Nod for AIDS Drug

Bookmark and Share

MUMBAI, May 5 (Reuters) - Indian drug maker Cipla Ltd said on Tuesday the U.S. Food and Drug Administration had granted tentative approval for its 300 mg variant of tenofovir disoproxil fumarate AIDS treatment drug.

MORE ON THIS TOPIC